In Vitro Activity of Ceftazidime-Avibactam against Isolates in a Phase 3 Open-Label Clinical Trial for Complicated Intra-Abdominal and Urinary Tract Infections Caused by Ceftazidime-Nonsusceptible Gram-Negative Pathogens

The in vitro activity of ceftazidime-avibactam was evaluated against 341 Gram-negative isolates from 333 patients in a randomized, phase 3 clinical trial of patients with complicated urinary tract or intra-abdominal infections caused by ceftazidime-nonsusceptible pathogens (NCT01644643). Ceftazidime...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Antimicrob Agents Chemother
Huvudupphovsmän: Stone, Gregory G., Bradford, Patricia A., Newell, Paul, Wardman, Angela
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2017
Ämnen:
Susceptibility
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5278708/
https://ncbi.nlm.nih.gov/pubmed/27872067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01820-16
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk